Egner PA - Search Results

1

Dietary aflatoxin-induced stunting in a novel rat model: evidence for toxin-induced liver injury and hepatic growth hormone resistance.

Knipstein B, Huang J, Barr E, Sossenheimer P, Dietzen D, Egner PA, Groopman JD, Rudnick DA. Knipstein B, et al. Among authors: egner pa. Pediatr Res. 2015 Aug;78(2):120-7. doi: 10.1038/pr.2015.84. Epub 2015 May 4. Pediatr Res. 2015. PMID: 25938735 Free PMC article.

2

Molecular dosimetry of urinary aflatoxin-N7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats.

Groopman JD, DeMatos P, Egner PA, Love-Hunt A, Kensler TW. Groopman JD, et al. Among authors: egner pa. Carcinogenesis. 1992 Jan;13(1):101-6. doi: 10.1093/carcin/13.1.101. Carcinogenesis. 1992. PMID: 1733561

3

Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver.

Davidson NE, Egner PA, Kensler TW. Davidson NE, et al. Among authors: egner pa. Cancer Res. 1990 Apr 15;50(8):2251-5. Cancer Res. 1990. PMID: 2317812

4

Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.

Kensler TW, Egner PA, Davidson NE, Roebuck BD, Pikul A, Groopman JD. Kensler TW, et al. Among authors: egner pa. Cancer Res. 1986 Aug;46(8):3924-31. Cancer Res. 1986. PMID: 2873884

5

Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.

Kensler TW, Egner PA, Dolan PM, Groopman JD, Roebuck BD. Kensler TW, et al. Among authors: egner pa. Cancer Res. 1987 Aug 15;47(16):4271-7. Cancer Res. 1987. PMID: 2886217

6

Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione.

Kensler TW, Egner PA, Trush MA, Bueding E, Groopman JD. Kensler TW, et al. Among authors: egner pa. Carcinogenesis. 1985 May;6(5):759-63. doi: 10.1093/carcin/6.5.759. Carcinogenesis. 1985. PMID: 3924431

7

Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz.

Egner PA, Gange SJ, Dolan PM, Groopman JD, Muñoz A, Kensler TW. Egner PA, et al. Carcinogenesis. 1995 Aug;16(8):1769-73. doi: 10.1093/carcin/16.8.1769. Carcinogenesis. 1995. PMID: 7634402

8

Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.

Primiano T, Egner PA, Sutter TR, Kelloff GJ, Roebuck BD, Kensler TW. Primiano T, et al. Among authors: egner pa. Cancer Res. 1995 Oct 1;55(19):4319-24. Cancer Res. 1995. PMID: 7671242

9

Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer.

Kensler TW, Gange SJ, Egner PA, Dolan PM, Muñoz A, Groopman JD, Rogers AE, Roebuck BD. Kensler TW, et al. Among authors: egner pa. Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(8):603-10. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9264273

10

Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China.

Wang JS, Shen X, He X, Zhu YR, Zhang BC, Wang JB, Qian GS, Kuang SY, Zarba A, Egner PA, Jacobson LP, Muñoz A, Helzlsouer KJ, Groopman JD, Kensler TW. Wang JS, et al. Among authors: egner pa. J Natl Cancer Inst. 1999 Feb 17;91(4):347-54. doi: 10.1093/jnci/91.4.347. J Natl Cancer Inst. 1999. PMID: 10050868 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters